lavendustin A

CAS No. 125697-92-9

lavendustin A( Lavendustin A | RG 14355 | RG-14355 | RG14355. )

Catalog No. M17228 CAS No. 125697-92-9

lavendustin A is a potent, cell-permeable inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 312 In Stock
5MG 537 In Stock
10MG 767 In Stock
25MG 1161 In Stock
50MG 1557 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    lavendustin A
  • Note
    Research use only, not for human use.
  • Brief Description
    lavendustin A is a potent, cell-permeable inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase.
  • Description
    Lavendustin A, also known as RG 14355, is a potent, cell-permeable inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase (IC50 = 11 nM). Lavendustin A shows cytotoxic effects on tumor cell lines. Lavendustin A enhances axon elongation in VHL gene-transfected neural stem cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Lavendustin A | RG 14355 | RG-14355 | RG14355.
  • Pathway
    Endocrinology/Hormones
  • Target
    CaMK
  • Recptor
    EGFR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    125697-92-9
  • Formula Weight
    381.38
  • Molecular Formula
    C21H19NO6
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 250 mg/mL 655.51 mM
  • SMILES
    O=C(O)c1cc(N(Cc2cc(O)ccc2O)Cc2ccccc2O)ccc1O
  • Chemical Name
    5-[[(2,5-Dihydroxyphenyl)methyl][(2-hydroxyphenyl)methyl]amino]-2-hydroxybenzoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Nam DH, et al. Synthesis and anticancer activity of chromone-based analogs of lavendustin A. Eur J Med Chem. 2010 Sep;45(9):4288-92
molnova catalog
related products
  • SCR7 pyrazine

    SCR7 is a specific DNA Ligase IV inhibitor, which blocks nonhomologous end-joining (NHEJ).

  • CAMKK2 inhibitor 4t

    CAMKK2 inhibitor 4t is a potent, selective, orally available, brain-penetrant CAMKK2 inhibitor with pIC50 of 8.5.

  • Calmodulin-Dependent...

    Calmodulin-Dependent Protein Kinase II (290-309) is a potent CaMK antagonist with an IC50 of 52 nM for inhibition of Ca2+/calmodulin-dependent protein kinase II.